Crossmark

Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation

Crossref DOI link: https://doi.org/10.1038/nchembio.2211

Published Online: 2016-10-31

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jones, Douglas S

Jenney, Anne P

Swantek, Jennifer L

Burke, John M http://orcid.org/0000-0002-1706-5973
Lauffenburger, Douglas A

Sorger, Peter K
License Information

Text and Data Mining valid from 2016-10-31
More Information

Article History

Received: 12 August 2015

Accepted: 16 August 2016

First Online: 31 October 2016

Competing interests

: J.M.B. and J.L.S. were employees at Boehringer Ingelheim Pharmaceuticals Inc. during the course of the studies; D.A.L. and P.K.S. were consultants to Boehringer Ingelheim Pharmaceuticals Inc.